Last $4.54 USD
Change Today +0.22 / 5.09%
Volume 2.8M
NVAX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James F. Young Ph.D.

Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee, Novavax, Inc.
AgeTotal Calculated CompensationThis person is connected to 66 board members in 5 different organizations across 6 different industries.

See Board Relationships
61$161,405

Background*

Dr. James F. Young, also known as Jim, Ph.D., is a Professor and Chairman, Academic Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Chairman, Endocrinology and Metabolism Institute. Dr. Young also serves as a Physician Director of Institutional Relations and Development and a Medical Director of the Kaufman Center for Heart Failure. Dr. Young served as the President, Research and Development of MedImmune LLC ...

Read Full Background

Corporate Headquarters*

20 Firstfield Road
Gaithersburg, Maryland 20878

United States

Phone: 240-268-2000
Fax: --

Board Members Memberships*

Former Director
Director
2010-Present
Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
2010-Present
Director
2013-Present
Chairman of the Board

Education*

Doctorate
Baylor College of Medicine
BS
Villanova University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$71,000
Total Calculated Compensation$161,405
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $4.54 USD +0.22

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$445.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Anthony S. Marucci M.B.A.Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
$871.4K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.